Structures by: Ang W. H.
Total: 48
(RuC29H32N2OCl)Cl2(CH3OH)
(RuC29H32N2OCl)Cl2(CH3OH)
Molecular pharmaceutics (2016) 13, 7 2543-2554
a=17.548(2)Å b=8.8135(12)Å c=20.148(3)Å
α=90° β=106.579(4)° γ=90°
(RuC28H29N2Cl2)Cl2(CH2Cl2)
(RuC28H29N2Cl2)Cl2(CH2Cl2)
Molecular pharmaceutics (2016) 13, 7 2543-2554
a=8.2070(3)Å b=12.9134(6)Å c=15.5705(7)Å
α=95.336(2)° β=104.273(2)° γ=96.960(2)°
C43H38N2OPd,C4H8O2
C43H38N2OPd,C4H8O2
Chem. Sci. (2016) 7, 9 6083
a=19.469(3)Å b=12.2196(16)Å c=16.391(2)Å
α=90.00° β=102.099(3)° γ=90.00°
C43H36F2N2OPd
C43H36F2N2OPd
Chem. Sci. (2016) 7, 9 6083
a=15.2388(13)Å b=14.5866(13)Å c=15.9868(14)Å
α=90° β=106.4424(18)° γ=90°
C23H25ClF6N3OPRu
C23H25ClF6N3OPRu
Journal of medicinal chemistry (2014) 57, 14 6043-6059
a=9.887(2)Å b=18.473(4)Å c=14.002(3)Å
α=90.00° β=104.589(3)° γ=90.00°
2(C49H42N2OPt),CHCl3
2(C49H42N2OPt),CHCl3
Chem. Sci. (2014) 5, 12 4819
a=12.4607(5)Å b=12.7920(5)Å c=14.1587(6)Å
α=67.9700(10)° β=85.6600(10)° γ=68.6710(10)°
C9H14Cl2N2O4Pt0.5(C3H6O)
C9H14Cl2N2O4Pt0.5(C3H6O)
Journal of medicinal chemistry (2012) 55, 17 7571-7582
a=13.660(3)Å b=9.867(2)Å c=23.937(6)Å
α=90.00° β=98.520(5)° γ=90.00°
Cis,cis,trans-diamminedichlorobis(4-vinylbenzoyl)platinum(IV)
C18H20Cl2N2O4Pt,
Journal of medicinal chemistry (2005) 48, 25 8060-8069
a=23.951(2)Å b=7.8455(13)Å c=32.732(3)Å
α=90.00° β=110.353(8)° γ=90.00°
Cis,cis,trans-diamminedichlorobis(4-cyanobenzoyl)platinum(IV)
C16H14Cl2N4O4Pt,2
Journal of medicinal chemistry (2005) 48, 25 8060-8069
a=7.8196(8)Å b=12.2969(11)Å c=16.4366(15)Å
α=81.492(8)° β=77.063(8)° γ=88.498(7)°
Cis,cis,trans-diamminedichlorobis(2-carboxylbenzoyl)platinum(IV)
C16H16Cl2N2O8Pt,C4H8O
Journal of medicinal chemistry (2005) 48, 25 8060-8069
a=8.9038(7)Å b=12.4327(12)Å c=12.8543(14)Å
α=62.590(11)° β=82.906(8)° γ=72.039(9)°
C6H11N2O,I
C6H11N2O,I
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=8.3743(6)Å b=12.0821(8)Å c=9.6014(8)Å
α=90.00° β=104.590(7)° γ=90.00°
C7H13N2O,I
C7H13N2O,I
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=15.2411(14)Å b=8.2598(7)Å c=32.681(2)Å
α=90.00° β=90.00° γ=90.00°
C8H15N2O2,I
C8H15N2O2,I
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=9.5223(5)Å b=8.0828(4)Å c=15.4060(12)Å
α=90.00° β=106.029(5)° γ=90.00°
C9H17N2O2,Br
C9H17N2O2,Br
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=7.1550(12)Å b=14.609(3)Å c=11.880(3)Å
α=90.00° β=105.698(16)° γ=90.00°
P-CymRuCl2(anthraimid)
C68H58BClN4Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=10.6994(5)Å b=29.8522(17)Å c=18.8571(10)Å
α=90.00° β=116.835(4)° γ=90.00°
[p-CymRuCl(anthraimid)2]BPh4
C27H26Cl2N2Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=14.340(2)Å b=12.4234(15)Å c=15.1560(17)Å
α=90.00° β=117.502(9)° γ=90.00°
P-CymRuCl2(phenoxbenzimid).EtOAc
C35H37Cl2N3O4Ru
Journal of medicinal chemistry (2007) 50, 9 2166-2175
a=12.658(3)Å b=14.916(5)Å c=17.958(4)Å
α=90.00° β=102.445(18)° γ=90.00°
C7H13N2O,I
C7H13N2O,I
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=9.4059(5)Å b=16.3399(9)Å c=13.6066(7)Å
α=90.00° β=91.547(4)° γ=90.00°
C9H17N2O2,I
C9H17N2O2,I
The journal of physical chemistry. B (2007) 111, 34 10095-10108
a=9.7948(13)Å b=13.0859(12)Å c=9.9372(14)Å
α=90.00° β=103.711(12)° γ=90.00°
C27H41AuNPS2
C27H41AuNPS2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 22 7355-7363
a=10.9925(4)Å b=13.0068(4)Å c=19.4730(6)Å
α=90° β=97.2120(13)° γ=90°
(C23H33AuNPS2),0.5(CH2Cl2)
(C23H33AuNPS2),0.5(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 22 7355-7363
a=35.3443(12)Å b=11.0755(4)Å c=30.2179(11)Å
α=90° β=118.9150(10)° γ=90°
C29H45AuNPS2
C29H45AuNPS2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 22 7355-7363
a=9.5931(2)Å b=11.3803(3)Å c=15.1080(3)Å
α=107.6920(10)° β=104.5720(10)° γ=96.8720(10)°
(C40H8Au8N8S16),0.5(CH2Cl2)
(C40H8Au8N8S16),0.5(CH2Cl2)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 22 7355-7363
a=26.0916(10)Å b=44.773(2)Å c=24.5430(10)Å
α=90° β=90° γ=90°
C16H20Cu2N6O11S4
C16H20Cu2N6O11S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 12 3833-3847
a=13.5205(8)Å b=11.0919(6)Å c=16.2446(9)Å
α=90° β=96.219(5)° γ=90°
C12H19CuN3O6S4
C12H19CuN3O6S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 12 3833-3847
a=6.3750(3)Å b=12.3166(9)Å c=13.7976(12)Å
α=75.444(7)° β=77.550(6)° γ=76.945(5)°
Cis,cis,trans-diamminedichlorodibenzoylplatinum(IV)
C14H16C12N2O4Pt,2
Journal of medicinal chemistry (2005) 48, 25 8060-8069
a=7.7485(8)Å b=18.294(3)Å c=18.356(4)Å
α=90.00° β=92.129(11)° γ=90.00°
[(3,3-dimethoxypropylbenzene)RuCl2]2
C22H32Cl4O4Ru2
Organometallics (2011) 30, 21 5965
a=13.0435(9)Å b=10.3684(7)Å c=9.7799(7)Å
α=90.00° β=100.889(2)° γ=90.00°
[(3,3-diethoxypropylbenzene)RuCl2]2
C26H40Cl4O4Ru2
Organometallics (2011) 30, 21 5965
a=14.922(4)Å b=10.535(3)Å c=9.700(3)Å
α=90.00° β=104.268(6)° γ=90.00°
[(3,3-diethoxypropylbenzene)RuCl2(pta)]
C19H32Cl2N3O2PRu
Organometallics (2011) 30, 21 5965
a=13.800(2)Å b=11.815(2)Å c=26.418(4)Å
α=90.00° β=90.00° γ=90.00°
C16H17NO3
C16H17NO3
Inorganic chemistry (2007) 46, 22 9048-9050
a=5.2366(5)Å b=12.6144(19)Å c=21.364(2)Å
α=90.00° β=96.086(8)° γ=90.00°
C22H27Cl2N4O3PRu,0.5(C3H7NO)
C22H27Cl2N4O3PRu,0.5(C3H7NO)
Inorganic chemistry (2007) 46, 22 9048-9050
a=20.93(2)Å b=17.304(8)Å c=6.992(3)Å
α=90.00° β=90.20(6)° γ=90.00°
C9H15N2,I
C9H15N2,I
Inorganic Chemistry (2006) 45, 26 10407-10409
a=9.3702(8)Å b=11.1295(10)Å c=12.3296(13)Å
α=72.026(9)° β=73.529(8)° γ=82.548(7)°
C8H13N2,I
C8H13N2,I
Inorganic Chemistry (2006) 45, 26 10407-10409
a=8.5957(14)Å b=9.8637(15)Å c=12.232(2)Å
α=90.00° β=90.00° γ=90.00°
C18H26N3O4PRu
C18H26N3O4PRu
Inorganic Chemistry (2006) 45, 22 9006-9013
a=11.2523(5)Å b=11.2529(5)Å c=15.8614(8)Å
α=90.00° β=90.00° γ=90.00°
C7H11N2,I
C7H11N2,I
Inorganic Chemistry (2006) 45, 26 10407-10409
a=6.2497(13)Å b=9.7754(19)Å c=8.3621(14)Å
α=90.00° β=108.911(9)° γ=90.00°
Cp*Rh(PTA)2Cl Cl 2HOH
C22H39ClN6P2Rh,2(H2O),Cl
Organometallics (2006) 25, 17 4090
a=9.1729(18)Å b=12.325(3)Å c=13.028(3)Å
α=78.66(3)° β=83.11(3)° γ=70.94(3)°
Cp*Rh(PTA)2Cl BPh4 MeOH
C46.70H61.81BClN6O0.705P2Rh
Organometallics (2006) 25, 17 4090
a=11.9850(10)Å b=30.388(2)Å c=13.0020(9)Å
α=90.000° β=107.800(7)° γ=90.000°
C7H7F6N4P
C7H7F6N4P
Organometallics (2007) 26, 7 1588
a=8.2759(13)Å b=15.020(4)Å c=9.024(2)Å
α=90.00° β=104.332(17)° γ=90.00°
C11H15F6N4P
C11H15F6N4P
Organometallics (2007) 26, 7 1588
a=8.2657(8)Å b=8.9473(6)Å c=10.6020(10)Å
α=105.391(8)° β=93.605(8)° γ=94.706(7)°
C7H7ClN4
C7H7ClN4
Organometallics (2007) 26, 7 1588
a=7.7665(10)Å b=15.8822(15)Å c=6.9241(6)Å
α=90.00° β=91.663(10)° γ=90.00°
C14H14B2F8N8
C14H14B2F8N8
Organometallics (2007) 26, 7 1588
a=5.5750(13)Å b=11.983(3)Å c=14.670(2)Å
α=90.00° β=98.534(16)° γ=90.00°
C16H24Cl4N6Pd
C16H24Cl4N6Pd
Organometallics (2007) 26, 7 1588
a=14.3813(14)Å b=10.8029(8)Å c=14.5861(12)Å
α=90.00° β=100.679(13)° γ=90.00°
C11H15ClN4
C11H15ClN4
Organometallics (2007) 26, 7 1588
a=5.2806(18)Å b=11.488(4)Å c=10.521(5)Å
α=90.00° β=98.96(3)° γ=90.00°
C18H28Cl4N6Pd
C18H28Cl4N6Pd
Organometallics (2007) 26, 7 1588
a=8.3277(4)Å b=11.3897(8)Å c=13.1294(9)Å
α=90.00° β=104.847(5)° γ=90.00°
C22H28Cl2N8Pd
C22H28Cl2N8Pd
Organometallics (2007) 26, 7 1588
a=11.3577(8)Å b=9.8994(8)Å c=12.3556(10)Å
α=90.00° β=113.087(7)° γ=90.00°
C22H30Cl4N8Pd
C22H30Cl4N8Pd
Organometallics (2007) 26, 7 1588
a=8.3363(7)Å b=8.8898(6)Å c=10.6673(11)Å
α=90.517(8)° β=107.260(8)° γ=113.689(7)°
C59H48O2P3Ru,0.5(F6P),0.5(CH2Cl2),0.5(CH2Cl2),0.5(Br),
C59H48O2P3Ru,0.5(F6P),0.5(CH2Cl2),0.5(CH2Cl2),0.5(Br),
Organometallics (2009) 28, 18 5568
a=16.4415(3)Å b=12.2233(3)Å c=27.9952(6)Å
α=90.00° β=107.0630(10)° γ=90.00°
Cp*RhCl2(PTA)
C16H27Cl2N3PRh
Organometallics (2006) 25, 17 4090
a=8.500(3)Å b=13.382(6)Å c=16.361(9)Å
α=90.00° β=90.00° γ=90.00°